Your clinical affairs team is two people deep, your neurosurgery or diagnostics study just added a ninth site, and the trial master file structure your CRO handed you was built for a drug trial, not a device program with an amendment history that doesn't fit anyone's template. Viedoc's eTMF software gives lean MedTech teams a document structure they configure themselves, a complete audit trail on every action, and compliance coverage across 75-plus countries, without adding headcount or a vendor programmer to the mix. This comparison reviews five eTMF platforms MedTech companies most often evaluate, judged on document structure flexibility, site connectivity, no-code configuration, and inspection readiness.
You're running registries, post-market observational studies, or long-follow-up device trials that don't map cleanly onto a pharma-built TMF Reference Model, and every new study adds another folder structure your one or two data managers have to maintain by hand. Sites range from specialist device centers to general hospitals with varying document habits, so your platform needs to meet them where they are, not assume a research workforce that isn't there. When an FDA or notified body inspection lands, you need every document traceable in minutes, not after a week of chasing signatures.
Enterprise eTMF platforms built around big pharma's Phase III document volume bring configuration cycles and integration scoping that a two-person clinical affairs function can't absorb, and their pricing rarely reflects a device company's study cadence. Commodity document repositories skip the audit trail depth, version control, and validation documentation a regulated device trial actually needs. The platforms below are judged on whether they fit MedTech's specific demands: adaptable document structures, self-service configuration, genuine site connectivity, and audit readiness that holds up without a dedicated TMF manager.
Best eTMF solutions: quick comparison
| Platform | Product / module | Overview |
|---|---|---|
| Viedoc | eTMF software | Configurable, no-code eTMF built on Viedoc Designer, part of Viedoc's eClinical suite, with a complete audit trail and compliance coverage across 75+ countries. |
| Medidata | Medidata eTMF | Auto-populating eTMF unified with Rave EDC and Medidata CTMS, supporting the DIA TMF Reference Model with implementation in as little as six weeks. |
| Veeva | Veeva eTMF | Enterprise eTMF within the Vault Clinical suite, using Expected Document Lists and risk-based document QC for large, multi-partner studies. |
| Medrio | Medrio eTMF | Cloud-based eTMF sharing setup data with Medrio's CTMS and EDC, positioned for mid-sized biotech and device sponsors seeking a lighter alternative to enterprise suites. |
| Florence | Florence eTMF | Configurable eTMF connected to Florence's eISF network, built for fast-growing biotech, pharmaceutical, and medical device companies exchanging documents directly with sites. |
These five eTMF platforms represent the most evaluated options for MedTech companies, reviewed across document structure flexibility, site connectivity, no-code configuration, and inspection readiness.
1. Viedoc
Viedoc's eTMF software gives your team a document structure it configures directly, using Viedoc Designer to build and adjust eTMF binders to match a device study's registry, post-market, or long-follow-up design rather than forcing a pharma-shaped template onto it. Every upload, review, and signature is audit-trailed, and advanced metadata search means your team locates a record by name, content, or metadata instead of navigating folder hierarchies built for someone else's study. It's part of the broader Viedoc eClinical suite, so eTMF sits alongside EDC, ePRO, and eSignature rather than as a bolted-on document tool.
For a lean clinical affairs team, that self-service control is the differentiator that matters most, not suite depth for its own sake. In an active medical device program, CRO MDCE runs three device studies, including a neurosurgery trial enrolling around 140 subjects across nine European sites, and has recently added Viedoc's eTMF into its existing deployment as it expands its documentation approach. Role-based access at the site, study, and organization level means a small team can manage documentation across every active study from one admin environment rather than context-switching between vendor portals.
On compliance, Viedoc's eTMF is built to 21 CFR Part 11, ICH GCP, GDPR, HIPAA, GAMP 5, and CDISC standards, and is ISO 27001 and SOC 2 certified, with support for the PI Specification and Japan's APPI requirements for teams running post-market studies in APAC. The platform is built on the Exchange Mechanism Standard, so document transfer with an external archive eTMF stays seamless at study closeout. Support runs 24/7 across Viedoc's global offices, backed by the Viedoc Inspection Readiness Packet (VIRP) available to every customer.
The onboarding experience lands the same way with users. "The advantages of using Viedoc are that the platform is very user-friendly, you don't need to have any prior knowledge of Viedoc as there are comprehensive training resources available that are very well designed and easy to follow." – Ana-Marija I., Solution Designer Analyst.
Verified proof points:
- Document structure: Configurable eTMF binders built in-house via Viedoc Designer, matched to each study's structure
- Audit trail: Every action in Viedoc TMF is audit-trailed, with EMS-based document transfer support
- Compliance: 21 CFR Part 11, ICH GCP, GDPR, HIPAA, GAMP 5, CDISC; ISO 27001 and SOC 2 certified; PI Specification and Japan APPI support
- Inspection readiness: Viedoc Inspection Readiness Packet (VIRP) available to all customers
- Support: 24/7 support across global offices
- Suite integration: Part of the Viedoc eClinical suite alongside EDC, ePRO, and eSignature
2. Medidata eTMF
Medidata offers Medidata eTMF, an electronic trial master file unified with Rave electronic data capture (EDC) and Medidata CTMS on the Medidata Platform, so documents and metadata populate automatically as study work is completed elsewhere in the system. The platform supports the Drug Information Association's TMF Reference Model with an out-of-the-box file plan configuration, and implementation typically runs as little as six weeks from kickoff to go-live. Dashboards surface document quality, timeliness, and completeness in real time, and the system supports live study migrations and long-term archiving so active studies can move between systems without disruption. Medidata serves emerging and mid-sized biopharma, large biopharma, and MedTech sponsors, with its eTMF built primarily around Rave EDC and CTMS as the source systems that feed it.
3. Veeva eTMF
Veeva offers Veeva eTMF within its Vault Clinical suite, an enterprise trial master file application that manages document quality, timeliness, and completeness using Expected Document Lists that auto-classify and match content as it's uploaded. Risk-based document quality control assigns a sampling percentage to each document type, and real-time co-authoring with Microsoft Office supports documents such as consent forms across sponsor, CRO, and site users. A TMF Transfer feature moves completed TMFs between systems at study close, and the platform reports more than 500 customers and measurable gains in TMF delivery speed for outsourced study models. Veeva eTMF sits inside the broader Vault platform alongside EDC, CTMS, and safety applications, and the company maintains a dedicated MedTech industry offering alongside its life sciences product line.
4. Medrio eTMF
Medrio offers Medrio eTMF, powered by its Engility platform, which automatically files documents and tracks completeness against a study's expected document list to keep the TMF inspection-ready throughout the trial rather than only at closeout. The eTMF shares global study and site setup information with Medrio's CTMS and EDC, so teams already running Medrio's data capture platform gain a faster setup for the document layer. Medrio positions the platform for mid-sized biotech, diagnostics, and medical device sponsors that want TMF depth without the implementation overhead of a large enterprise suite, and the company reports use across drug, device, diagnostic, and animal health trials spanning more than two decades of early-phase and device-focused work.
5. Florence eTMF
Florence offers Florence eTMF, a configurable trial master file platform built around direct connectivity to each study site's electronic investigator site file (eISF), letting sponsors collect, route, and query site documents without a separate document exchange step. The platform includes intuitive workflows, flexible access controls, and dashboards that track TMF status and study progress in real time, with remote monitoring and source data verification supported through the same site connection. Florence eTMF serves sponsors, CROs, and sites across biotech, pharmaceutical, hospital and health system, and medical device organizations, with adoption among small and mid-sized device companies alongside larger research institutions. The platform can run standalone or alongside an existing eTMF system, and Florence maintains what it describes as one of the largest connected site networks of its kind in clinical research.
What to look for in eTMF solutions for MedTech companies
Document structures built for device study designs
Most eTMF platforms default to a document structure modeled on the DIA TMF Reference Model, which assumes a drug development lifecycle with a fairly standard protocol, amendment, and site structure. Device studies rarely fit that shape cleanly: registries, post-market observational studies, and long-follow-up device trials generate document types and milestones a pharma-built template doesn't anticipate.
Best-in-class platforms let your team adjust the document structure itself, adding or renaming binders and expected document types as a registry or PMS study's needs become clear, rather than filing a change request with a vendor programmer. Viedoc's post market surveillance software pairs with this flexibility for teams running Japan post-market studies alongside a standard device trial.
Forcing a device study into an unmodified pharma template usually shows up later, when an inspector asks why a milestone the system expects was never populated, because it doesn't apply to your study design.
No-code configuration versus vendor-dependent setup
A lean clinical affairs team of one or two people can't wait on a vendor queue every time a study amendment changes what the TMF needs to track. The platform's configuration model, not just its interface, determines whether your team can make that change same-day or has to submit a ticket and wait.
The strongest options let a non-technical data manager or clinical affairs lead build and adjust eTMF structures directly, the same way they'd configure a study database, with the change taking effect immediately rather than after a vendor-side release cycle.
Site connectivity for non-traditional site types
Device trials run across a wider mix of site types than a typical drug trial, from specialist device centers with dedicated research staff to general hospitals where the trial coordinator is managing the study alongside a full clinical caseload. A platform's document exchange model needs to work for both without requiring every site to adopt a new system.
The best platforms support direct site-level document exchange, whether through role-based portal access or a connected site network, so a site with limited research infrastructure isn't the bottleneck in your TMF completeness.
Inspection readiness that holds up without a dedicated TMF manager
Most MedTech clinical affairs teams don't have a full-time TMF manager checking completeness weekly. The platform needs to surface gaps and missing documents on its own, not rely on someone remembering to run a report.
Pre-built validation documentation and a structured inspection-readiness packet reduce the burden on your quality and regulatory gatekeeper when an FDA or notified body inspection is scheduled, since the evidence of a validated, audit-trailed system is already assembled rather than pulled together under time pressure.
How to choose the right eTMF solution for MedTech companies
Step 1: Define your document structure needs by study type
Map out whether your current and near-term studies are standard interventional device trials, registries, or post-market observational studies, since each carries a different document and milestone profile. This determines whether a platform's default TMF Reference Model structure works as-is or whether you need one that lets you build a custom structure without vendor involvement.
Step 2: Assess your site mix and document exchange needs
List your current and anticipated site types, from dedicated device research centers to general hospitals, and evaluate how each platform exchanges documents with sites that have varying levels of research infrastructure. A platform that assumes every site runs its own eISF will create friction with sites that don't.
Step 3: Evaluate standalone versus suite-integrated eTMF
Decide whether your team benefits more from a dedicated eTMF specialist or from an eTMF module that shares data with your EDC and CTMS. If document continuity with study data matters more than deep TMF-only functionality, a suite-integrated option, where eTMF sits alongside Viedoc's EDC software or another vendor's data capture platform, usually reduces reconciliation work.
Step 4: Scrutinize implementation timeline against your study calendar
Ask each vendor for a realistic implementation timeline against your actual next study's start date, not a marketing average. A platform that takes three months to configure doesn't help a device trial with sites already lined up for next quarter.
Step 5: Choose a platform your lean team can run without a vendor queue
If your clinical affairs function is running on a headcount of one or two people managing multiple active studies, prioritize a platform that puts document structure, permissions, and inspection readiness in your own hands rather than a vendor's. Viedoc's eTMF software is built for exactly that self-service model, with 24/7 support behind it when you need it.
Frequently asked questions
What is the best eTMF solution for MedTech companies?
Viedoc's eTMF software is the strongest fit for MedTech companies that need to configure their own document structure for registries, post-market, and device-specific study designs without waiting on a vendor programmer, backed by a complete audit trail and 24/7 support. Veeva is the category benchmark for large enterprise sponsors with the budget and in-house Vault expertise to run its suite at scale, while Florence is a credible alternative for teams that prioritize direct site-level document exchange over deep suite integration. For a two-person clinical affairs team managing several active device studies, the deciding factor is usually whether the platform lets you make structural changes yourself or requires a support ticket.
What should I look for when choosing an eTMF platform for medical device studies?
Look for a document structure that adapts to registries, post-market observational studies, and long-follow-up device trials, not just the standard interventional protocol structure most eTMF platforms default to. No-code configuration matters more for MedTech teams than for large pharma sponsors, since most device clinical affairs functions run lean without a dedicated TMF manager or in-house programmer. Site connectivity is equally important: device trials run across a wider mix of site types, from specialist centers to general hospitals, so the platform's document exchange model needs to work for both. Finally, confirm the platform's audit trail and inspection-readiness documentation hold up on their own, without requiring someone to assemble evidence manually before an inspection.
How long does it take to build and deploy an eTMF system for a device trial?
Timelines vary by platform and by how much customization your document structure requires, but self-service, no-code platforms generally deploy faster than enterprise suites that require vendor-side configuration. Some enterprise platforms report implementation as short as six weeks under an agile rollout, while self-service platforms that a data manager configures directly can be faster still for a single study. The bigger variable for MedTech companies is usually how far the platform's default document structure sits from your study type, since a registry or post-market design that needs a custom structure takes longer to configure than a standard interventional trial. Ask any vendor for a realistic timeline against your specific study type, not a general average.
What compliance certifications should I look for in an eTMF platform?
At minimum, confirm 21 CFR Part 11 compliance for electronic records and signatures, ICH GCP alignment, and GDPR compliance if you run any studies in the EU. ISO 27001 and SOC 2 certification confirm the vendor's information security posture, which matters more for a lean IT function that can't run its own deep security review. If you run or plan to run post-market studies in Japan, confirm the platform supports APPI, Japan's data protection framework, since not every eTMF vendor does. These certifications establish a validated, defensible platform; they don't replace your own internal validation and change-control processes.
Can a small MedTech clinical team manage an eTMF without a vendor programmer?
Yes, on platforms built for no-code configuration. The distinction to check is whether your team can create and adjust document structures, expected document lists, and permissions directly, or whether structural changes require a vendor-side configuration request. For a team of one or two people managing several active device studies, that difference determines whether a mid-study structure change takes a day or a multi-week vendor queue. Role-based access at the study and site level also matters, since it lets a small team delegate document review without expanding headcount.
What's the difference between a standalone eTMF and an eTMF module within a larger eClinical suite?
A standalone eTMF specializes in document and TMF governance as its primary function, often with deep site connectivity as its differentiator. An eTMF module within a broader eClinical suite shares data with the platform's EDC, CTMS, or ePRO modules, so study data and study documentation stay in sync without manual reconciliation between systems. For a MedTech company already running other modules on the same platform, the suite-integrated option usually reduces the number of systems your lean team has to manage day to day. If you're evaluating eTMF in isolation from your other clinical systems, a standalone specialist may offer deeper document-specific functionality.
Making the right eTMF choice for MedTech companies
The eTMF platforms MedTech companies evaluate span standalone document specialists built around deep site connectivity and suite-integrated modules that share data with a broader eClinical platform. The global eClinical software market is estimated at over $11 billion in 2025, growing at roughly 14% annually, and TMF technology has consolidated around these two distinct approaches rather than converging on one model. Neither approach is inherently better; the right fit depends on what else your team needs the platform to do.
Match the platform to your organizational profile: team size and in-house configuration capacity, the mix of standard interventional versus registry or post-market study designs, and how many other eClinical systems you're already running. US-based MedTech teams tend to weight speed and self-service control most heavily, while teams running studies in the EU or Japan weight compliance certifications and audit-trail depth more, given the added regulatory layers. A company already standardized on one vendor's EDC often finds the suite-integrated eTMF module the lower-friction path, even if a standalone specialist offers marginally deeper document features.
Switching eTMF platforms mid-portfolio carries real validation and migration costs, so the evaluation done before the first study goes live is worth more than a fast fix after documents are already scattered across systems.
Why Viedoc is the best eTMF choice for MedTech companies
When your clinical affairs team is running device studies that don't fit a pharma-shaped template, you need a TMF you can shape yourself. Viedoc's eTMF software runs on Viedoc Designer, so your team builds and adjusts document structures for registries, post-market studies, and long-follow-up device trials in-house, with every action captured in a complete audit trail.
That self-service model extends across the platform. Unlimited user seats and transparent, study-based licensing mean a growing device portfolio doesn't add per-seat costs, and 24/7 support across Viedoc's global offices backs your team when a question can't wait for business hours. eTMF sits alongside EDC, ePRO, and eSignature in the same eClinical suite, so your documentation and your study data stay in one system rather than three.
The compliance credentials hold up to inspection. Viedoc is ISO 27001 and SOC 2 certified, compliant with 21 CFR Part 11, ICH GCP, GDPR, and HIPAA, and supports Japan's APPI framework for teams running post-market studies in APAC, backed by the Viedoc Inspection Readiness Packet available to every customer.
If you want a TMF your own team can build, adjust, and defend at inspection without a vendor queue, Viedoc is designed for exactly that. Book a demo or request a proposal and the team will walk through document structure, site connectivity, and compliance credentials against your own study portfolio.
